MBX Biosciences, Valuation
| MBX Stock | 19.83 1.14 5.44% |
At this time, the entity appears to be overvalued. MBX Biosciences, Common secures a last-minute Real Value of USD17.06 per share. The latest price of the entity is USD19.83. Our model forecasts the value of MBX Biosciences, Common from inspecting the entity fundamentals such as shares owned by insiders of 3.08 %, and Number Of Shares Shorted of 345.33 K as well as reviewing its technical indicators and probability of bankruptcy.
Enterprise Value 613.9 M |
Overvalued
Today
Please note that MBX Biosciences,'s price fluctuation is slightly risky at this time. Calculation of the real value of MBX Biosciences, Common is based on 3 months time horizon. Increasing MBX Biosciences,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since MBX Biosciences, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MBX Stock. However, MBX Biosciences,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 19.83 | Real 17.06 | Hype 19.47 |
The intrinsic value of MBX Biosciences,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence MBX Biosciences,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of MBX Biosciences, Common helps investors to forecast how MBX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MBX Biosciences, more accurately as focusing exclusively on MBX Biosciences,'s fundamentals will not take into account other important factors: MBX Biosciences, Total Value Analysis
MBX Biosciences, Common is now forecasted to have company total value of 613.91 M with market capitalization of 676.25 M, debt of 156.65 M, and cash on hands of . Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the MBX Biosciences, fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
613.91 M | 676.25 M | 156.65 M |
MBX Biosciences, Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of MBX suggests not a very effective usage of assets in November.MBX Biosciences, Ownership Allocation
MBX Biosciences, Common maintains a total of 31.85 Million outstanding shares. Over half of MBX Biosciences,'s outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company has, if the real value of the entity is less than the current market value, you may not be able to make money on it.About MBX Biosciences, Valuation
Our relative valuation model uses a comparative analysis of MBX Biosciences,. We calculate exposure to MBX Biosciences,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MBX Biosciences,'s related companies.Additional Tools for MBX Stock Analysis
When running MBX Biosciences,'s price analysis, check to measure MBX Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MBX Biosciences, is operating at the current time. Most of MBX Biosciences,'s value examination focuses on studying past and present price action to predict the probability of MBX Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MBX Biosciences,'s price. Additionally, you may evaluate how the addition of MBX Biosciences, to your portfolios can decrease your overall portfolio volatility.